Impaired Wound Healing with Imatinib Mesylate Therapy
| Autor: | Cornelia Erfurt-Berge, Moritz Ronicke |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
Advanced and Specialized Nursing Wound Healing medicine.medical_specialty medicine.drug_class business.industry Antineoplastic Agents 030208 emergency & critical care medicine Dermatology Middle Aged Gastroenterology digestive system diseases Tyrosine-kinase inhibitor Impaired wound healing 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Imatinib mesylate Internal medicine Skin Ulcer Imatinib Mesylate medicine Humans business Gastrointestinal Neoplasms |
| Zdroj: | Advances in Skin & Wound Care. 34:109-111 |
| ISSN: | 1538-8654 1527-7941 |
| DOI: | 10.1097/01.asw.0000725176.48771.0f |
| Popis: | Medication-induced ulcers are generally rare. Although the tyrosine kinase inhibitor imatinib mesylate is frequently prescribed, the occurrence of ulcers related to the medication has not been previously described. Herein, the authors report a case of a patient with impaired wound healing that was attributed to imatinib mesylate treatment. Providers should maintain suspicion for medication-induced ulcers, particularly if treatment for the presumed underlying cause of an ulcer fails. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|